Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway

Bone is a frequent site of metastasis from breast cancer, and a desirable drug could suppress tumor growth as well as metastasis-linked bone loss. Currently, no drug is able to cure breast cancer–associated bone metastasis. In this study, we focused on statins that are known to inhibit cholesterol p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:FASEB J
Auteurs principaux: Wang, Luqi, Wang, Yue, Chen, Andy, Teli, Meghana, Kondo, Rika, Jalali, Aydin, Fan, Yao, Liu, Shengzhi, Zhao, Xinyu, Siegel, Amanda, Minami, Kazumasa, Agarwal, Mangilal, Li, Bai-Yan, Yokota, Hiroki
Format: Artigo
Langue:Inglês
Publié: Federation of American Societies for Experimental Biology 2019
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6894072/
https://ncbi.nlm.nih.gov/pubmed/31585508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201901388R
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires